Verona Pharma plc Holding(s) In Company Tr-1: Standard Form For Notification Of Major Holdings
February 07 2020 - 2:00AM
UK Regulatory
TIDMVRP
LONDON, Feb. 07, 2020 (GLOBE NEWSWIRE) -- TR-1: Standard form for
notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the
relevant issuer and to the FCA in Microsoft Word format
if possible)(i)
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
1a. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are attached(ii)
: Verona Pharma plc
------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer
(please mark with an "X" if appropriate)
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Non-UK issuer
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------
2. Reason for the notification (please mark the appropriate
box or boxes with an "X")
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------
An acquisition or disposal of financial instruments
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------
An event changing the breakdown of voting rights
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------
Other (please specify)(iii) :
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------
3. Details of person subject to the notification obligation(iv)
Name Arix Bioscience plc
City and country of registered office (if applicable)
4. Full name of shareholder(s) (if different from
3.)(v)
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Name
------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------
City and country of registered office (if applicable)
------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------
5. Date on which the threshold was crossed or reached(vi)
: 5 February 2020
------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------
6. Date on which issuer notified (DD/MM/YYYY): 6 February 2020
------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------
7. Total positions of person(s) subject to the notification
obligation
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
% of voting rights attached to shares (total of 8. % of voting rights through financial instruments Total of both in
A) (total of 8.B 1 + 8.B 2) % (8.A + 8.B) Total number of voting rights of issuer(vii)
--------------------------------------------------- -------------------------------------------------- ------------------------------------------------ ---------------- --------------------------------------------
Resulting situation on the date on which threshold
was crossed or reached Below 3% Below 3% 105,326,638
--------------------------------------------------- -------------------------------------------------- ------------------------------------------------ ---------------- --------------------------------------------
Position of previous notification (if applicable) 3.2% 3.2%
--------------------------------------------------- ------------------------------------------------ --------------------------------------------
8. Notified details of the resulting situation on
the date on which the threshold was crossed or reached(viii)
-------------------------------------------------------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
-------------------------------------------------------------------------------------------------------------------------------------------------------------------
Class/type of Number of voting rights(ix) % of voting rights
shares
ISIN code (if possible)
--------------------------
Direct Indirect Direct Indirect
(Art 9 of Directive (Art 10 of Directive (Art 9 of Directive (Art 10 of Directive
2004/109/EC) (DTR5.1) 2004/109/EC) (DTR5.2.1) 2004/109/EC) (DTR5.1) 2004/109/EC) (DTR5.2.1)
------------------------ ------------------------ ---------------------------- ----------------------------------------------------- ------------------------
GB00BYW2KH80 Below 3% Below 3% Below 3% Below 3%
-------------------------- ------------------------ ---------------------------- ----------------------------------------------------- ------------------------
SUBTOTAL 8. A Below 3% Below 3%
-------------------------- ------------------------------------------------------ -------------------------------------------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a)
of Directive 2004/109/EC (DTR5.3.1.1 (a))
-------------------------------------------------------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting rights that may be acquired if the % of voting rights
instrument date(x) Conversion Period(xi) instrument is
exercised/converted.
-------------------------- ---------------------- ---------------------------- ------------------------------------------------------- ------------------------
SUBTOTAL 8. B 1
---------------------------- ------------------------------------------------------- ------------------------
B 2: Financial Instruments with similar economic effect
according to Art. 13(1)(b) of Directive 2004/109/EC
(DTR5.3.1.1 (b))
-------------------------------------------------------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Conversion Physical or cash Number of voting rights % of voting rights
instrument date(x) Period (xi) settlement(xii)
------------------------ ------------------------ -------------------------- -------------------------- ------------------------
SUBTOTAL 8.B.2
-------------------------- ----------------------------- ------------------------
9. Information in relation to the person subject to
the notification obligation (please mark the applicable
box with an "X")
Person subject to the notification obligation is not
controlled by any natural person or legal entity and
does not control any other undertaking(s) holding
directly or indirectly an interest in the (underlying)
issuer(xiii)
Full chain of controlled undertakings through which
the voting rights and/or the financial instruments
are effectively held starting with the ultimate controlling
natural person or legal entity(xiv) (please add additional
rows as necessary)
-------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------
Name(xv) % of voting rights if it equals or is higher than % of voting rights through financial instruments if Total of both if it equals or is higher than the notifiable
the notifiable threshold it equals or is higher than the notifiable threshold threshold
-------- ------------------------------------------------- ----------------------------------------------------- -------------------------------------------------------------
10. In case of proxy voting, please identify:
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Name of the proxy holder
----------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------
The number and % of voting rights held
----------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------
The date until which the voting rights will be held
----------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------
11. Additional information(xvi)
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Place of completion London, United Kingdom
------------------- ----------------------
Date of completion 6 February 2020
------------------- ----------------------
(END) Dow Jones Newswires
February 07, 2020 02:00 ET (07:00 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jul 2023 to Jul 2024
